Telesis Bio, Inc. TBIO
0.01 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.01155 Day range 0.01155
0.0001 52-week range 0.15
- YTD
- -80.00%
- 1 year
- -16.67%
News
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
globenewswire.com Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities
benzinga.com Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000 
benzinga.com Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket - benzinga.com Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
benzinga.com Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase - benzinga.com Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge
- benzinga.com Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
globenewswire.com Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic…
globenewswire.com Telesis Bio Reports Second Quarter and First Half 2024 Financial Results SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,…
benzinga.com Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
globenewswire.com Telesis Bio Reports First Quarter 2024 Financial Results SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,…
globenewswire.com Telesis Bio Announces Reverse Stock Split SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (the Company) (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
globenewswire.com Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the…
globenewswire.com Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
globenewswire.com Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,…
investorplace.com Why Is Telesis Bio (TBIO) Stock Up 29% Today? Telesis Bio (NASDAQ: TBIO ) stock is on the rise Friday as the synthetic biology company's shares experienced heavy trading this morning. Shares of TBIO stock are off to a strong start on Friday with…
benzinga.com Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
globenewswire.com Telesis Bio Reports Third Quarter 2023 Financial Results SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter…- benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
globenewswire.com Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023 SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023…
globenewswire.com Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 647 companies set new 52-week lows.
globenewswire.com Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation…
globenewswire.com Telesis Bio Appoints William J. Kullback Chief Financial Officer SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial…
seekingalpha.com Telesis Bio, Inc. (TBIO) Q2 2023 Earnings Call Transcript Telesis Bio, Inc. (NASDAQ:TBIO ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Todd Nelson - Founder, Chief Executive Officer Eric Esser - President, Chief…
globenewswire.com Telesis Bio Reports Second Quarter 2023 Financial Results -- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year -- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year- benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
globenewswire.com Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023 SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter 2023…
globenewswire.com Telesis Bio to Present at Jefferies Healthcare Conference 2023 SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder…
globenewswire.com Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023 Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery
globenewswire.com Telesis Bio to Present at SynBioBeta 2023 Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery Highlighting application of the Molecular Biology Workstation to accelerating vaccine and…- benzinga.com Earnings Scheduled For May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its…
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning trading, 101 companies set new 52-week highs.
- benzinga.com 63 Biggest Movers From Yesterday Gainers
- benzinga.com 41 Stocks Moving In Friday's Mid-Day Session Gainers
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday This morning 85 companies set new 52-week highs.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 558 companies set new 52-week highs.